ATOZET

This brand name is authorized in Austria, Australia, Germany, Ecuador, Spain, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, Netherlands, Poland, Romania, Singapore

Active ingredients

The drug ATOZET contains a combination of these active pharmaceutical ingredients (APIs):

1 Atorvastatin UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL. Read about Atorvastatin

2 Ezetimibe UNII EOR26LQQ24 - EZETIMIBE

Ezetimibe is in a new class of lipid-lowering compounds that selectively inhibit the intestinal absorption of cholesterol. The molecular target of ezetimibe is the sterol transporter, Niemann-Pick C1-Like 1 (NPC1L1), which is responsible for the intestinal uptake of cholesterol. Read about Ezetimibe

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ATOZET Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10BA05		C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10376D, 10377E, 10392Y, 10393B
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 10538255, 10538261, 10538315, 10538321, 10538396, 10538410, 10538491, 10538516, 12478155, 12478161, 12494065, 12494094, 12494148, 12494154, 12494160, 12494177, 12520360, 12520377, 12520383, 12536272, 12536289, 12536295, 12536303, 12733541, 12733558, 12733564, 12733570, 13154621, 13154644, 13154667, 13154696, 13899700, 14055128, 14270140, 14270157, 14270163, 14270186, 14348735, 14404652, 14437723, 14437746, 14437752, 15257868, 15266560, 15266577, 15408155, 15408161, 15424220, 15530293, 15571518, 15571524, 15571530, 16036595, 16227786, 16506405, 16506434, 16606271, 16606288, 16606294, 16606325, 16665210, 16686169
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1964-MEE-0316, 2062-MEE-0516
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 3400928005557, 3400928005786, 34009288005557IP, 79224, 79226, 79227
Country: HK	Department of Health Drug Office	Identifier(s): 64636, 64637
Country: IE	Health Products Regulatory Authority	Identifier(s): 36858, 36859, 36862, 36863
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7899, 7900, 7901, 7902
Country: JP	医薬品医療機器総合機構	Identifier(s): 2189101F1020, 2189101F2026
Country: MT	Medicines Authority	Identifier(s): MA031/02401, MA031/02402, MA031/02403, MA031/02404
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 022M2017
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 122793, 122807, 122815
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100346646, 100346669, 100346681, 100346706
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68310001, W68310002, W68310003, W68310004, W68310005, W68310006, W68311001, W68311002, W68311003, W68311004, W68311005, W68311006, W68312001, W68312002, W68312003, W68312004, W68312005, W68312006, W68313001, W68313002, W68313003, W68313004, W68313005, W68313006
Country: SG	Health Sciences Authority	Identifier(s): 15113P, 15114P, 15115P, 15116P